Literature DB >> 10742114

Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis.

M P Bulman1, K Kusumi, T M Frayling, C McKeown, C Garrett, E S Lander, R Krumlauf, A T Hattersley, S Ellard, P D Turnpenny.   

Abstract

Spondylocostal dysostosis (SD, MIM 277300) is a group of vertebral malsegmentation syndromes with reduced stature resulting from axial skeletal defects. SD is characterized by multiple hemivertebrae, rib fusions and deletions with a non-progressive kyphoscoliosis. Cases may be sporadic or familial, with both autosomal dominant and autosomal recessive modes of inheritance reported. Autosomal recessive SD maps to a 7.8-cM interval on chromosome 19q13.1-q13.3 that is homologous with a mouse region containing a gene encoding the Notch ligand delta-like 3 (Dll3). Dll3 is mutated in the X-ray-induced mouse mutant pudgy (pu), causing a variety of vertebrocostal defects similar to SD phenotypes. Here we have cloned and sequenced human DLL3 to evaluate it as a candidate gene for SD and identified mutations in three autosomal recessive SD families. Two of the mutations predict truncations within conserved extracellular domains. The third is a missense mutation in a highly conserved glycine residue of the fifth epidermal growth factor (EGF) repeat, which has revealed an important functional role for this domain. These represent the first mutations in a human Delta homologue, thus highlighting the critical role of the Notch signalling pathway and its components in patterning the mammalian axial

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742114     DOI: 10.1038/74307

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  99 in total

1.  Chromosomal localization, genomic characterization, and mapping to the Noonan syndrome critical region of the human Deltex (DTX1) gene.

Authors:  L Lee; J Dowhanick-Morrissette; A Katz; L Jukofsky; I D Krantz
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

2.  Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects.

Authors:  Sarbjit S Nijjar; Lorraine Wallace; Heather A Crosby; Stefan G Hubscher; Alastair J Strain
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 3.  Concordia discors: duality in the origin of the vertebrate tail.

Authors:  Gregory R Handrigan
Journal:  J Anat       Date:  2003-03       Impact factor: 2.610

Review 4.  Genetic disorders of the skeleton: a developmental approach.

Authors:  Uwe Kornak; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2003-07-31       Impact factor: 11.025

Review 5.  Osteoblastogenesis regulation signals in bone remodeling.

Authors:  C Zuo; Y Huang; R Bajis; M Sahih; Y-P Li; K Dai; X Zhang
Journal:  Osteoporos Int       Date:  2012-06       Impact factor: 4.507

6.  miRNA-34c regulates Notch signaling during bone development.

Authors:  Yangjin Bae; Tao Yang; Huan-Chang Zeng; Philippe M Campeau; Yuqing Chen; Terry Bertin; Brian C Dawson; Elda Munivez; Jianning Tao; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2012-04-12       Impact factor: 6.150

Review 7.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

Review 8.  Integration of Drosophila and Human Genetics to Understand Notch Signaling Related Diseases.

Authors:  Jose L Salazar; Shinya Yamamoto
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 9.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

Review 10.  Epidemiology of adolescent idiopathic scoliosis.

Authors:  Markus Rafael Konieczny; Hüsseyin Senyurt; Rüdiger Krauspe
Journal:  J Child Orthop       Date:  2012-12-11       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.